---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-105390"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2026-09-30T23:48:20+00:00"
generated_at: "2026-10-12T14:12:08.134655+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sanara shareholders approve MiMedx merger; HSR waiting period runs to Oct 15 after refiling

## Summary
- Shareholders approved the merger with MiMedx at the Sept 30, 2026 special meeting: 6,372,989 votes for, 1,944 against and 36,494 abstained.
- Advisory vote on merger-related executive compensation passed 5,841,470 for, 75,247 against and 494,710 abstained.
- MiMedx withdrew and refiled its HSR notification Sept 15, 2026, starting a new 30-day waiting period expiring 11:59 p.m. ET Oct 15, 2026.
- 6,411,427 shares (69.78% of the 9,188,035 outstanding as of the Sept 1 record date) were present, so the adjournment proposal was not needed.
- Merger Agreement dated July 29, 2026 calls for Mustang Merger Sub to merge into Sanara, which survives as a wholly-owned MiMedx subsidiary.

## SEC filing metadata
- accession: 0001213900-26-105390
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2026-09-30T23:48:20+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000121390026105390/0001213900-26-105390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000121390026105390/ea0307287-8k_sanara.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-105390
- JSON: https://secwatch.observer/filing/0001213900-26-105390.json
- Plain text: https://secwatch.observer/filing/0001213900-26-105390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.